IRIS Accounts Production v25.2.0.378 03402812 Board of Directors 1.9.23 31.8.24 31.8.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh034028122023-08-31034028122024-08-31034028122023-09-012024-08-31034028122022-08-31034028122022-09-012023-08-31034028122023-08-3103402812ns15:EnglandWales2023-09-012024-08-3103402812ns14:PoundSterling2023-09-012024-08-3103402812ns10:Director12023-09-012024-08-3103402812ns10:PrivateLimitedCompanyLtd2023-09-012024-08-3103402812ns10:SmallEntities2023-09-012024-08-3103402812ns10:AuditExempt-NoAccountantsReport2023-09-012024-08-3103402812ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-08-3103402812ns10:SmallCompaniesRegimeForAccounts2023-09-012024-08-3103402812ns10:FullAccounts2023-09-012024-08-310340281212023-09-012024-08-3103402812ns10:Director22023-09-012024-08-3103402812ns10:CompanySecretary12023-09-012024-08-3103402812ns10:RegisteredOffice2023-09-012024-08-3103402812ns5:CurrentFinancialInstruments2024-08-3103402812ns5:CurrentFinancialInstruments2023-08-3103402812ns5:Non-currentFinancialInstruments2024-08-3103402812ns5:Non-currentFinancialInstruments2023-08-3103402812ns5:ShareCapital2024-08-3103402812ns5:ShareCapital2023-08-3103402812ns5:SharePremium2024-08-3103402812ns5:SharePremium2023-08-3103402812ns5:RetainedEarningsAccumulatedLosses2024-08-3103402812ns5:RetainedEarningsAccumulatedLosses2023-08-3103402812ns5:NetGoodwill2023-09-012024-08-3103402812ns5:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3103402812ns5:PatentsTrademarksLicencesConcessionsSimilar2023-09-012024-08-3103402812ns5:PlantMachinery2023-09-012024-08-3103402812ns5:NetGoodwill2023-08-3103402812ns5:IntangibleAssetsOtherThanGoodwill2023-08-3103402812ns5:NetGoodwill2024-08-3103402812ns5:IntangibleAssetsOtherThanGoodwill2024-08-3103402812ns5:NetGoodwill2023-08-3103402812ns5:IntangibleAssetsOtherThanGoodwill2023-08-3103402812ns5:PlantMachinery2023-08-3103402812ns5:PlantMachinery2024-08-3103402812ns5:PlantMachinery2023-08-3103402812ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-3103402812ns5:WithinOneYearns5:CurrentFinancialInstruments2023-08-3103402812ns5:RetainedEarningsAccumulatedLosses2023-09-012024-08-3103402812ns5:RetainedEarningsAccumulatedLosses2022-09-012023-08-31
REGISTERED NUMBER: 03402812 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 AUGUST 2024

FOR

CHEMICARE (COVENTRY) LIMITED

CHEMICARE (COVENTRY) LIMITED (REGISTERED NUMBER: 03402812)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


CHEMICARE (COVENTRY) LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 AUGUST 2024







DIRECTORS: D Joshi
Mrs R Joshi





SECRETARY: D Joshi





REGISTERED OFFICE: Cashs Business Centre
1st Floor
228 Widdrington Road
Coventry
West Midlands
CV1 4PB





REGISTERED NUMBER: 03402812 (England and Wales)





ACCOUNTANTS: Dattani
Chartered Accountants
Scottish Provident House
76/80 College Road
Harrow
Middlesex
HA1 1 BQ

CHEMICARE (COVENTRY) LIMITED (REGISTERED NUMBER: 03402812)

BALANCE SHEET
31 AUGUST 2024

31.8.24 31.8.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 233 259
Tangible assets 5 4,120 5,494
4,353 5,753

CURRENT ASSETS
Stocks 60,016 53,091
Debtors 6 155,900 170,293
Cash at bank and in hand 23,091 30,122
239,007 253,506
CREDITORS
Amounts falling due within one year 7 174,834 189,118
NET CURRENT ASSETS 64,173 64,388
TOTAL ASSETS LESS CURRENT
LIABILITIES

68,526

70,141

CREDITORS
Amounts falling due after more than one
year

8

18,107

28,116
NET ASSETS 50,419 42,025

CAPITAL AND RESERVES
Called up share capital 1,200 1,200
Share premium 49,900 49,900
Retained earnings (681 ) (9,075 )
SHAREHOLDERS' FUNDS 10 50,419 42,025

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CHEMICARE (COVENTRY) LIMITED (REGISTERED NUMBER: 03402812)

BALANCE SHEET - continued
31 AUGUST 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 August 2025 and were signed on its behalf by:





D Joshi - Director


CHEMICARE (COVENTRY) LIMITED (REGISTERED NUMBER: 03402812)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

1. STATUTORY INFORMATION

Chemicare (Coventry) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2011, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

CHEMICARE (COVENTRY) LIMITED (REGISTERED NUMBER: 03402812)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2024

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 15 (2023 - 15 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
Goodwill assets Totals
£    £    £   
COST
At 1 September 2023
and 31 August 2024 585,770 6,000 591,770
AMORTISATION
At 1 September 2023 585,770 5,741 591,511
Charge for year - 26 26
At 31 August 2024 585,770 5,767 591,537
NET BOOK VALUE
At 31 August 2024 - 233 233
At 31 August 2023 - 259 259

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 September 2023
and 31 August 2024 49,835
DEPRECIATION
At 1 September 2023 44,341
Charge for year 1,374
At 31 August 2024 45,715
NET BOOK VALUE
At 31 August 2024 4,120
At 31 August 2023 5,494

CHEMICARE (COVENTRY) LIMITED (REGISTERED NUMBER: 03402812)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2024

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.24 31.8.23
£    £   
Trade debtors 124,559 140,469
Other debtors 31,341 29,824
155,900 170,293

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.24 31.8.23
£    £   
Trade creditors 127,074 148,374
Taxation and social security 16,249 16,144
Other creditors 31,511 24,600
174,834 189,118

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.8.24 31.8.23
£    £   
Bank loans 18,107 28,116

9. SECURED DEBTS

The bank loan is under the Bounce Back Loan Scheme and secured by way of a guarantee provided by the United Kingdom government.

10. RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS
31.8.24 31.8.23
£    £   
Profit/(loss) for the financial year 8,394 (51,637 )
Dividends - (17,000 )
8,394 (68,637 )
Opening shareholders' fund - 2023 - 110,662
Net addition to shareholders' funds 8,394 42,025
Opening shareholders' funds 42,025 -
Closing shareholders' funds 50,419 42,025